Conclusion of a non-exclusive discount agreement pursuant to § 130a Sect. 8 SGB V for medicinal products containing the active substance Tolvaptan excluding medicinal products with uniform potencies (ATC code: G04BX21).
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Tolvaptan ausgenommen Arzneimittel mit einheitlichen Wirkstärken (ATC-Code: G04BX21).
Germany
Contract
BuyerAOK Niedersachsen. Die Gesundheitskasse.
TypeSupplies
Estimated valuevalue not published
Published18 March 2026
CategoryMedical equipment & pharma · CPV 33000000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Horn GmbH · Stutensee | 3 | 2025 |
| AbZ Pharma GmbH · Ulm | 1 | 2022 |
| amasol GmbH | 1 | 2026 |
| Binect GmbH · Weiterstadt | 1 | 2026 |
| COMRAMO AG · Hannover | 1 | 2026 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
2022109
2023117
2024169
2025238
2026126
Who knows the rhythm prepares instead of reacting.
555
days until the deadline — Saturday 26 February at 09:00
How to bid
Read the full notice — Original + documents
Goes directly to this tender on Vergabemarktplatz (cosinex). The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →